These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2780612)

  • 1. Potentiation of norepinephrine-induced vasoconstrictions by neuropeptide Y in isolated canine carotid artery.
    Gintautas J; Chou SY; Longmore W; Abadir AR
    Proc West Pharmacol Soc; 1989; 32():327-8. PubMed ID: 2780612
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y-induced contraction and its desensitization through the neuropeptide Y receptor subtype in several rat veins.
    Tsurumaki T; Muraoka O; Yamaguchi T; Higuchi H
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S23-7. PubMed ID: 12688392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
    J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F; Argiolas L; Ruvolo G; del Basso P
    Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities and differences in the postjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature.
    Owen MP
    J Pharmacol Exp Ther; 1993 May; 265(2):887-95. PubMed ID: 8496832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation by neuropeptide Y of histamine H1 receptor-mediated contraction in rat blood vessels.
    Piao H; Nagai S; Tsurumaki T; Niki T; Higuchi H
    Vascul Pharmacol; 2007 Apr; 46(4):260-70. PubMed ID: 17169617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prejunctional AT(1) receptor subtype-dependent modification of neurotransmitter releases in canine isolated splenic arteries.
    Komiyama J; Yang XP; Chiba S
    Auton Autacoid Pharmacol; 2003; 23(5-6):297-305. PubMed ID: 15255814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries.
    Hondeghem LM; Ayad MJ; Robertson RM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):808-13. PubMed ID: 3795042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: influence of the endothelium.
    Galle J; Schollmeyer P; Wanner C
    Eur Heart J; 1993 Nov; 14 Suppl I():111-7. PubMed ID: 8293762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y induces potent contraction of arterial vascular smooth muscle via an endothelium-independent mechanism.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1988 Sep; 134(1):157-8. PubMed ID: 3239419
    [No Abstract]   [Full Text] [Related]  

  • 12. [The mode of low responsiveness of isolated canine internal carotid artery to exogenous norepinephrine].
    Kawai Y; Ohhasi T
    Kokyu To Junkan; 1986 Oct; 34(10):1093-8. PubMed ID: 3797840
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropeptide Y stimulates DNA synthesis in human vascular smooth muscle cells through neuropeptide Y Y1 receptors.
    Nilsson T; Edvinsson L
    Can J Physiol Pharmacol; 2000 Mar; 78(3):256-9. PubMed ID: 10721818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of vascular endothelium in the potentiation of vasoconstrictor responses by neuropeptide Y.
    Hieble JP; Ruffolo RR; Daly RN
    J Hypertens Suppl; 1988 Dec; 6(4):S239-42. PubMed ID: 3241208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action.
    Wahlestedt C; Edvinsson L; Ekblad E; Håkanson R
    J Pharmacol Exp Ther; 1985 Sep; 234(3):735-41. PubMed ID: 3928874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clonidine, yohimbine and idazoxan on isolated carotid arteries of dog.
    Gintautas J; Abadir AR; Kwalburn M; Mayda J; Kraynack BJ
    Proc West Pharmacol Soc; 1996; 39():45-6. PubMed ID: 8895965
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of neuropeptide Y on cochlear blood flow in guinea pigs.
    Itou M; Ogawa K; Inoue Y; Sato M; Kanzaki J
    Acta Otolaryngol; 2001 Jul; 121(5):573-8. PubMed ID: 11583388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
    You J; Edvinsson L; Bryan RM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):77-84. PubMed ID: 11149671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin potentiation of the norepinephrine response in vascular smooth muscle.
    Flaim SF; Zora JA; Zelis R
    Gen Pharmacol; 1979; 10(3):201-6. PubMed ID: 467959
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of norepinephrine on the dog common carotid, coronary and renal arteries: in vitro studies.
    Chelly J; Tsao C; Nath R; Doursout MF; Buckley J
    Eur J Pharmacol; 1986 Jan; 120(1):137-9. PubMed ID: 3948912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.